量化英国罗尔斯·罗伊斯员工持续性肌肉骨骼疼痛的负担：一项真实世界的横断面调查。

Quantifying The Burden of Persistent Musculoskeletal Pain in Employees at Rolls-Royce in The United Kingdom: A Real-World Cross-Sectional Survey.

机构信息

From the Pfizer Ltd, Tadworth, United Kingdom (L.A., R.R., L.S.-R.); Pfizer Inc, New York, NY (B.E.); Rolls-Royce PLC, Derby, United Kingdom (affiliation for David Roomes under which the work was done) (D.R., K.G.); Bristol Myers Squibb, Chester, United Kingdom (current affiliation for David Roomes) (D.R.); Adelphi Real World, Bollington, United Kingdom (G.T.-S., L.M., H.W.); and Centre for Applied Research in Health, University of Huddersfield, Huddersfield, United Kingdom (K.B.).

出版信息

J Occup Environ Med. 2023 Jun 1;65(6):e424-e434. doi: 10.1097/JOM.0000000000002845. Epub 2023 Mar 25.

DOI:10.1097/JOM.0000000000002845

PMID:36977358

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10227944/

Abstract

OBJECTIVE

We aimed to investigate the burden of persistent musculoskeletal (MSK) pain in Rolls-Royce UK employees.

METHODS

Employees with ( n = 298) and without ( n = 329) persistent MSK pain completed a cross-sectional survey. Weighted regression analyses were conducted to compare sickness absence, work ability, workplace accommodations/adaptations, and emotional well-being between these cohorts, controlling for confounders.

RESULTS

Persistent MSK pain (particularly back pain) had a significant impact on physical work ability and was associated with increased sickness absence due to pain. Many employees (56%) had not disclosed their condition to their managers. Of these, 30% felt uncomfortable doing so, and 19% of employees reported insufficient support at work for their pain.

CONCLUSIONS

These findings highlight the importance of creating a workplace culture that encourages the disclosure of work-relevant pain, enabling organizations to consider improved, tailored support for employees.

摘要